Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab to Participate at the Jefferies Global Healthcare Conference 2024-05-22 19:00
GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services 2024-05-22 13:00
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016 2024-05-22 09:16
YS Biopharma Announces Results of Extraordinary General Meeting 2024-05-22 04:15
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub 2024-05-21 21:00
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy 2024-05-21 20:00
Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia 2024-05-21 17:52
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome 2024-05-21 17:35
BGI Team Successfully Reaches the Summit of Mount Everest 2024-05-21 16:41
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis 2024-05-21 12:01
Proto Axiom Launches The Challenger Summit: Australia's Premier Biotech Pitch-Event with over $250,000 in Grant Financing 2024-05-21 11:28
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease 2024-05-21 08:55
Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery 2024-05-20 20:00
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director 2024-05-20 18:00
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON 2024-05-20 14:30
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval 2024-05-20 14:07
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC) 2024-05-20 08:20
Qilian International plans to adjust industrial investment 2024-05-17 22:00
GV Announces Cooperation with Top 500 Company in China 2024-05-17 20:30
1 34 35 36 37 38 451